Povidone-iodine in Ophthalmology: Background and Update

JOURNAL TITLE: Highlights of Ophthalmology

Author
1. Carlos Rocha de Lossada
2. Rahul Rachwani Anil
ISSN
1024-6983
DOI
10.5005/hoe-10101-49603
Volume
49
Issue
6ENG
Publishing Year
2021
Pages
11
Author Affiliations
    1. Hospital Regional Universitario de Malaga Spain
    1. Qvision (Vithas Almeria) Hospital Virgen de las Nieves, Granada. Ceuta Medical Center Spain
  • Article keywords
    Povidone-iodine, iodine, endophthalmitis, cataracts, anti-VEGF

    Abstract

    Historically, iodine in its iodized stain form has been used for more than a century as an antiseptic. However, despite its effectiveness, its use has been largely compromised by its numerous side effects, such as burning, irritation and allergies. Guidelines on the use of povidone-iodine (PVI) in evidence-based ophthalmology place this solution at a concentration of 5-10% as the gold standard in the prophylaxis of endophthalmitis prior to cataract surgery and intravitreal injections. The purpose of this review is to present the current evidence on the use of PVI in ophthalmology, in addition to its indications not yet approved at concentrations below 5%.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved